Investment Summary

Eight Roads Invests In makeO

On August 6, 2021, private equity firm Eight Roads invested in healthcare services company makeO

Investment Highlights
  • This is Eight Roads’ 14th transaction in the Healthcare Services sector.
  • This is Eight Roads’ 33rd transaction in India.

Investment Summary

Date 2021-08-06
Target makeO
Sector Healthcare Services
Investor(s) Eight Roads
Deal Type Venture

Target

makeO

Mumbai, India
makeO provides its customers with at-home teeth alignment treatment at competitive prices. makeO is based in Mumbai, Maharashtra.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 258 of 293
Sector: Healthcare Services M&A 14 of 16
Type: Venture M&A Deals 234 of 266
Country: India M&A 33 of 37
Year: 2021 M&A 18 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-03 Inceptio Technology

Shanghai, China

Inceptio Technology focuses on the transformation of line-haul logistics by providing Transportation-As-A-Service (TaaS) to logistic customers. Inceptio Technology was founded in 2018 and is based in Shanghai, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-11 Nebula Genomics

San Francisco, California, United States

Nebula Genomics provides consumers access to affordable and secure whole-genome sequencing via its online portal. Nebula’s solution is powered by the innovations of George Church, Ph.D. Dr. Church has pioneered the development of multiple DNA sequencing methods, including molecular multiplexing approaches that enable next-generation DNA sequencing (NGS) as well as nanopore sequencing. Nebula Genomics was founded in 2016 and is based in San Francisco, California.

Sell $15M